Related Experiment Videos
Human papillomaviruses and cervical cancer
1Ludwig Institute for Cancer Research, São Paulo, Brazil.
Advances in Cancer Research
|January 1, 1997
Summary
Certain human papillomaviruses (HPVs) cause cervical cancer. Persistent high-risk HPV infections, especially with high viral load, increase disease progression risk, informing prevention strategies.
Area of Science:
- Oncology
- Virology
- Epidemiology
Background:
- Human papillomavirus (HPV) is recognized as the primary etiological agent of cervical cancer.
- Over 70 HPV types exist, with about half found in genital mucosa, categorized by oncogenic risk (low vs. high).
- High-risk HPVs express proteins disrupting cell growth, potentially causing chromosome instability and cell transformation.
Purpose of the Study:
- To review the role of HPV in cervical cancer etiology and progression.
- To discuss the concept of low and high oncogenic risk HPV types.
- To highlight the significance of HPV persistence and viral burden in disease development.
Main Methods:
- Review of molecular and epidemiological studies over the last 20 years.
- Analysis of HPV type associations with normal tissues, benign lesions, and cervical cancer.
- Examination of factors influencing HPV infection persistence and disease progression.
Main Results:
- Persistent high-risk HPV infections are linked to cervical disease progression.
- The majority of HPV infections are transient and not carcinogenic.
- Viral burden may correlate with the risk of disease progression.
Conclusions:
- Understanding HPV natural history is crucial for cervical cancer prevention.
- Prospective studies are needed to identify determinants of HPV persistence.
- HPV testing utility in cervical cancer screening programs requires further definition.